Found 293 matching trials
A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)
PHASE2This study will assess the safety, tolerability and glucose-lowering effica...
Location
Multiple Locations
Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents
PHASE2To exam in the effect of a combination of low dose Metformin and Spironolac...
Location
Children's Mercy Hospital
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
PHASE4The purpose of this study was to determine whether monotherapy treatment wi...
Location
University Medical Center Ljubljana
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
PHASE2This was a four month dose ranging study followed by a 24 to 48 month exten...
Location
Anasazi Internal Medicine
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
NAThe Pre-DICTED (Pre-Diabetes Intervention and Continued Tracking to Ease-ou...
Location
Singapore General Hospital
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus
PHASE2Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyp...
Location
Faculty of medicine, Tanta University
Diabetes Management for Primary Healthcare Centers.
NAThe purpose of this study, "Integrating diabetes care into Primary Healthca...
Status
Active Not Recruiting
Location
Kagini PHC, Abuja Municipal Area council (AMAC)
Medication in Early Diabetes (MED) Study
PHASE4This study compares metformin (current first-line medication) to pioglitazo...
Location
Menzies School of Health Research
Glyburide vs Glucovance in the Treatment of GDM
EARLY_PHASE1A randomized comparison of glyburide to glucovance (metformin -glyburide) i...
A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)
PHASE2This study will test the effectiveness and safety of treatment with MK-0893...
Location
Multiple Locations